Angelos Halaris

Summary

Affiliation: Loyola University Medical Center
Country: USA

Publications

  1. pmc Combination therapy or monotherapy for the depressed type of schizoaffective disorder
    Lubomira Izáková
    Psychiatric Clinic, Faculty of Medicine Comenius University and Faculty Hospital, Bratislava, Slovakia
    Neuropsychiatr Dis Treat 5:91-101. 2009
  2. doi request reprint Inflammation, heart disease, and depression
    Angelos Halaris
    Department of Psychiatry and Behavioral Neuroscience, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA
    Curr Psychiatry Rep 15:400. 2013
  3. ncbi request reprint Agmatine : metabolic pathway and spectrum of activity in brain
    Angelos Halaris
    Department of Psychiatry and Behavioral Neurosciences, Loyola University Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153, USA
    CNS Drugs 21:885-900. 2007
  4. ncbi request reprint Comorbidity between depression and cardiovascular disease
    A Halaris
    Department of Psychiatry, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA
    Int Angiol 28:92-9. 2009
  5. doi request reprint A primary care focus on the diagnosis and treatment of major depressive disorder in adults
    Angelos Halaris
    Loyola University Stritch School of Medicine, Maywood, IL 60153, USA
    J Psychiatr Pract 17:340-50. 2011
  6. doi request reprint Pro-inflammatory biomakers in depression: treatment with venlafaxine
    John E Piletz
    Department of Psychiatry, Loyola University Chicago, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA
    World J Biol Psychiatry 10:313-23. 2009
  7. doi request reprint VEGF and depression: a comprehensive assessment of clinical data
    Anne Clark-Raymond
    Stritch School of Medicine, Loyola University Chicago, Loyola University Medical Center, USA
    J Psychiatr Res 47:1080-7. 2013
  8. pmc Platelet imidazoline receptors as state marker of depressive symptomatology
    John Piletz
    Department of Psychiatry and Behavioral Neuroscience, Loyola University Medical Center, Maywood, IL 60153, United States
    J Psychiatr Res 42:41-9. 2008
  9. ncbi request reprint Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells
    Meng Yang Zhu
    Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
    Cell Mol Neurobiol 23:865-72. 2003

Research Grants

Collaborators

Detail Information

Publications9

  1. pmc Combination therapy or monotherapy for the depressed type of schizoaffective disorder
    Lubomira Izáková
    Psychiatric Clinic, Faculty of Medicine Comenius University and Faculty Hospital, Bratislava, Slovakia
    Neuropsychiatr Dis Treat 5:91-101. 2009
    ..Both treatments were comparable in terms of antidepressant efficacy...
  2. doi request reprint Inflammation, heart disease, and depression
    Angelos Halaris
    Department of Psychiatry and Behavioral Neuroscience, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA
    Curr Psychiatry Rep 15:400. 2013
    ..This results in a shunt in tryprophan metabolism away from serotonin formation and down the kynurenine pathway with resulting formation of neurotoxic metabolites. ..
  3. ncbi request reprint Agmatine : metabolic pathway and spectrum of activity in brain
    Angelos Halaris
    Department of Psychiatry and Behavioral Neurosciences, Loyola University Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153, USA
    CNS Drugs 21:885-900. 2007
    ..The possible roles and/or beneficial effects of agmatine in stress-related disorders, such as depression, anxiety and post-traumatic stress disorder, merit further investigation...
  4. ncbi request reprint Comorbidity between depression and cardiovascular disease
    A Halaris
    Department of Psychiatry, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA
    Int Angiol 28:92-9. 2009
    ..Comorbid depression must be treated vigorously and SSRIs exert beneficial action not only in ameliorating depression but also in reversing platelet activation and inflammation, thereby reducing cardiovascular morbidity and mortality...
  5. doi request reprint A primary care focus on the diagnosis and treatment of major depressive disorder in adults
    Angelos Halaris
    Loyola University Stritch School of Medicine, Maywood, IL 60153, USA
    J Psychiatr Pract 17:340-50. 2011
    ..Considerations that strongly influence long-term patient adherence, including tolerability and cost, are also reviewed...
  6. doi request reprint Pro-inflammatory biomakers in depression: treatment with venlafaxine
    John E Piletz
    Department of Psychiatry, Loyola University Chicago, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA
    World J Biol Psychiatry 10:313-23. 2009
    ..09), and MCP-1 (P=0.02), suggesting that these biomarkers may have become selectively lowered in the serotonergic dose range of venlafaxine. This is the first report of venlafaxine's possible effect on pro-inflammatory biomarkers...
  7. doi request reprint VEGF and depression: a comprehensive assessment of clinical data
    Anne Clark-Raymond
    Stritch School of Medicine, Loyola University Chicago, Loyola University Medical Center, USA
    J Psychiatr Res 47:1080-7. 2013
    ....
  8. pmc Platelet imidazoline receptors as state marker of depressive symptomatology
    John Piletz
    Department of Psychiatry and Behavioral Neuroscience, Loyola University Medical Center, Maywood, IL 60153, United States
    J Psychiatr Res 42:41-9. 2008
    ..It has been hypothesized that IR-1 up-regulation during the depressive episode may be a state marker for depressive symptomatology. The goal of the present study was to address the state versus trait question...
  9. ncbi request reprint Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells
    Meng Yang Zhu
    Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
    Cell Mol Neurobiol 23:865-72. 2003
    ..1...

Research Grants4

  1. IMIDAZOLINE RECEPTORS IN DEPRESSION--CLINICAL STUDIES
    Angelos Halaris; Fiscal Year: 2001
    ....
  2. IMIDAZOLINE RECEPTORS IN DEPRESSION--CLINICAL STUDIES
    Angelos Halaris; Fiscal Year: 1999
    ....
  3. IMIDAZOLINE RECEPTORS IN DEPRESSION--CLINICAL STUDIES
    Angelos Halaris; Fiscal Year: 2000
    ....